Enanta Pharmaceuticals Inc (ENTA)
Stock-Based Compensation
$15.28M
TTM · Period ending: · USD
ENTA Stock-Based Compensation
Latest reported$15.28Mperiod ending
Latest reported$15.28Mperiod ending
ENTA TTM Stock-Based Comp ($650.00K → $15.28M)
TTM stock-based compensation
High-resolution chart · PNG
ENTA stock-based compensation history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 15,275,000 | |
| 15,769,000 | |
| 16,709,000 | |
| 18,565,000 | |
| 22,249,000 | |
| 23,489,000 | |
| 24,362,000 | |
| 26,795,000 | |
| 25,793,000 | |
| 27,374,000 | |
| 29,176,000 | |
| 28,216,000 | |
| 28,333,000 | |
| 28,938,000 | |
| 28,046,000 | |
| 26,969,000 | |
| 25,489,000 | |
| 23,361,000 | |
| 22,170,000 | |
| 20,991,000 | |
| 20,383,000 | |
| 19,662,000 | |
| 19,360,000 | |
| 19,575,000 | |
| 19,342,000 | |
| 18,752,000 | |
| 18,481,000 | |
| 19,226,000 | |
| 18,824,000 | |
| 18,685,000 | |
| 17,568,000 | |
| 15,845,000 | |
| 14,945,000 | |
| 14,022,000 | |
| 13,924,000 | |
| 13,071,000 | |
| 12,371,000 | |
| 11,739,000 | |
| 10,629,000 | |
| 9,354,000 | |
| 8,641,000 | |
| 7,755,000 | |
| 6,802,000 | |
| 5,838,000 | |
| 4,836,000 | |
| 4,028,000 | |
| 3,351,000 | |
| 2,682,000 | |
| 2,173,000 | |
| 1,636,000 | |
| 1,141,000 | |
| 1,063,000 | |
| 1,020,000 | |
| 876,000 | |
| 650,000 | |
| 424,000 | |
| 253,000 |